COLUMBIA NYC ENGINEERING AN EDIBLE PROBIOTIC CONSORTIUM TO REGULATE - - PowerPoint PPT Presentation

columbia nyc
SMART_READER_LITE
LIVE PREVIEW

COLUMBIA NYC ENGINEERING AN EDIBLE PROBIOTIC CONSORTIUM TO REGULATE - - PowerPoint PPT Presentation

COLUMBIA NYC ENGINEERING AN EDIBLE PROBIOTIC CONSORTIUM TO REGULATE APPETITE AND DIGESTION Jacky Cheung, Samuel Magaziner, Suppawat Kongthong, Hudson Lee, Kenya Velez THE RISE OF METABOLIC DISEASES CHANGES IN CALORIC INTAKE PER CAPITA PER


slide-1
SLIDE 1

ENGINEERING AN EDIBLE PROBIOTIC CONSORTIUM TO REGULATE APPETITE AND DIGESTION

COLUMBIA NYC

Jacky Cheung, Samuel Magaziner, Suppawat Kongthong, Hudson Lee, Kenya Velez

slide-2
SLIDE 2

THE RISE OF METABOLIC DISEASES

CHANGES IN CALORIC INTAKE PER CAPITA PER DAY OVER TIME IN THE U.S COMPARISON OF AVERAGE CALORIC INTAKE PER CAPITA AROUND THE WORLD

OBESITY & DIABETES MEDICAL EXPENSES QUALITY OF LIFE

slide-3
SLIDE 3

FOOD AS THE SOLUTION – NOT THE PROBLEM

HISTORICAL AND PROJECT SALES OF YOGURT IN THE UNITED STATES WHAT ARE PROBIOTICS? Live Bacteria & Yeasts That Improve Health DIGESTIVE FUNCTIONS IMMUNE SYSTEM FUNCTIONS SUPPORT FRIENDLY BACTERIA “Let food be thy medicine and medicine be they food” - Hippocrates

GOAL: ENGINEER A PROBIOTIC FOOD THAT COUNTERS OBESITY AND DIABETES

slide-4
SLIDE 4

METHOD TO COUNTER OBESITY AND DIABETES

GLUCAGON-LIKE PEPTIDE I (GLP-I) INSULIN LEVELS SATIETY LEVELS PEPTIDE YY (PYY) APPETITE LEVELS GI MOVEMENT GHRELIN APPETITE LEVELS CARDIOVASCULAR HEALTH

slide-5
SLIDE 5

ENGINEERING AN EDIBLE PROBIOTIC TO SECRETE GUT PEPTIDES TO REGULATE APPETITE AND DIGESTION

  • E. Coli Nissle

Lactobacillus Reuteri phoA pelB Lp_3050 M6 GLP-1 Ghrelin PYY Signal Peptides Signal Peptides (SPs)

x

Gut Peptides (GPs)

slide-6
SLIDE 6

EXPERIMENTAL SETUP: SIGNAL PEPTIDE SECRETION

Anhydro-Tetracycline (or Nisin in Lactobacillus model) pTet

Hormone SP His-Tag Lysate 1X101 1X10-1 1X10-2 1X102 1X101 1X10-1 Supernatant His-tagged Protein Concentrate supernatant + lyse cells Grow-up, spin down cell pellet, extract supernatant Blot

slide-7
SLIDE 7

RESULTS: HORMONES (NO SIGNAL PEPTIDE)

Ghrelin PYY Glp-1

Note: We expect to see no secretion

Lysate (Left) 1x101 Supernatant (Right) 1x102 Lysate (Left) 1x10-1 Supernatant (Right) 1x101 Lysate (Left) 1x10-2 Supernatant (Right) 1x10-1

slide-8
SLIDE 8

RESULTS: SUCCESS WITH PHOA-GLP1 (IMPORTANCE OF INDUCTION TIME)

Lysate (Left) 1x101 Supernatant (Right) 1x102 Lysate (Left) 1x10-1 Supernatant (Right) 1x101 Lysate (Left) 1x10-2 Supernatant (Right) 1x10-1 PhoA-Glp1(36hr induction) PhoA-Glp1 (12hr Induction) Lysate 1x101 Supernatant 1x101 Supernatant 1x10-1

Note: Same construct, Wildly different Results; also improvement of previous biobrick BBa_K817000

slide-9
SLIDE 9

RESULTS: SUCCESS WITH PELB

Lysate 1x101 Supernatant 1x101 Supernatant 1x102 PelB-Glp1 (36hr) PelB-PYY (36hr) Here we demonstrate the generalizable nature of signal peptide secretion

slide-10
SLIDE 10

IMPLEMENTING A CONSORTIUM TO PROVIDE REGULATIONS AND SAFETY MECHANISM FEATURES

COMMUNICATION REGULATION SAFETY OUR SYSTEM IS TO BE TIGHTLY REGULATED AS A SAFETY PRECAUTION

slide-11
SLIDE 11

THE SYSTEM: SAFETY, REGULATION, COMMUNICATION, AND SECRETION MEET

slide-12
SLIDE 12

THE SYSTEM BREAKDOWN: THE AHL FACTORY

slide-13
SLIDE 13

THE SYSTEM BREAKDOWN: TARGET SECRETION

slide-14
SLIDE 14

THE SYSTEM BREAKDOWN: TIME-DELAYED CELL LYSIS (BBA_K1848006)

slide-15
SLIDE 15

RESULTS

  • Timer-Lysis Cassette system submitted as

biobrick (BBa_K1848006)

  • System successfully cloned in
  • Time constraints prevented its testing
  • However…
slide-16
SLIDE 16

1 3 2 Heat whole milk to 185ºF Cool to 115ºF and add engineered L. reuteri + yogurt starter culture Incubate at 37ºC for 8 hr and refrigerate

IN PRACTICUM: YOGURT

Note: Yogurt was not intended for human consumption, nor did it leave the lab

slide-17
SLIDE 17

SURVEYING THE PUBLIC

  • Online survey
  • Polled public on GMOs and probiotics, to inform design of safety measures and yogurt

products

  • Informed survey takers about probiotics and GMOs
  • Twitter and blog

Comfort level in consuming probiotics (On scale of 1-5) before informing the survey takers about probiotics Comfort level in consuming probiotics (On scale of 1-5) after informing the survey takers about probiotics

slide-18
SLIDE 18

THE FUTURE: YOGHURT (OR LOOKING WHEY INTO THE FUTURE)

  • Going Forward:
  • 1. Finish screen of submitted quorum sensing system
  • 2. Move system into L. reuteri
  • 3. Test active system’s ability to function within yogurt

culture

  • 4. Screen more hormones
  • The Foreseeable future:
  • Catalog of peptide secreting yogurt
  • Biotech branch based around personalized consumable

medicines

slide-19
SLIDE 19

IN SUMMATION…

  • We managed to:

1.

Submit 6 bio-bricks (5 of which are well- characterized) (BBa_K1848001-006)

2.

Successfully secrete 3 gut hormones and 2 signal peptides in E. coli

3.

Develop a promising system quorum sensing based secretion and lysis

4.

Move an engineered L. reuteri system in yogurt

5.

Poll on public opinion of probiotics and willingness to consume GMOs

6.

Have an amazing summer and lay the foundation for future iGEM teams from our University

Student Team Members The Whole Team

slide-20
SLIDE 20

ATTRIBUTIONS AND ACKNOWLEDGMENT

  • Undergraduate Team Members: Suppawat Kongthong, Jacky Cheung, Kenya

Velez, Hudson Lee, Samuel Magaziner

  • Mentors: Nathan Johns, Sway Chen, and Sonja Billerbeck
  • PIs: Harris Wang, Virginia Cornish, Ken Shepard, Dana Pe’er
slide-21
SLIDE 21

CITATIONS

  • "Adult Obesity Facts." Centers for Disease Control and Prevention. Centers for

Disease Control and Prevention, 16 June 2015. Web. 21 Sept. 2015.

  • Peppers, Margot. "Daily Calorie Intake of Countries across the World Revealed...

and (surprise) the U.S. Tops the List at 3,770." Daily Mail. Mail Online, 12 Aug.

  • 2014. Web. 21 Sept. 2015.
  • "U.S Yogurt Market - Statistics and Facts." Www.statista.com. Statista, n.d. Web. 21
  • Sept. 2015.
  • Vimala, S, A W Norhanom, and M Yadav. “Anti-Tumour Promoter Activity in

Malaysian Ginger Rhizobia Used in Traditional Medicine.” British Journal of Cancer 80.1-2 (1999): 110–116. PMC.

  • Claesen, Jan, and Michael A. Fischbach. “Synthetic Microbes As Drug Delivery

Systems.” ACS Synthetic Biology 4.4 (2015): 358–364. PMC.

  • Bienenstock, John et al. “New Insights into Probiotic Mechanisms: A Harvest from

Functional and Metagenomic Studies.”Gut Microbes 4.2 (2013): 94–100.PMC.

  • Duan, Faping, Katherine L. Curtis, and John C. March. “Secretion of Insulinotropic

Proteins by Commensal Bacteria: Rewiring the Gut To Treat Diabetes .” Applied and Environmental Microbiology 74.23 (2008): 7437–7438.PMC. Web. 18 Sept. 2015.

  • T. Tan, S. Bloom. “Gut hormones as therapeutic agents in treatment of diabetes and
  • besity” Curr Opin Pharmacol, 13 (2013), pp. 996–1001
  • Skibicka, Karolina P et al. “Role of Ghrelin in Food Reward: Impact of Ghrelin on

Sucrose Self-Administration and Mesolimbic Dopamine and Acetylcholine Receptor Gene Expression.” Addiction Biology 17.1 (2012): 95–107. PMC. Web. 18 Sept. 2015.

  • Vahl TP

, Paty BW, Fuller BD, Prigeon RL, D'Alessio DA. Effects of GLP-1-(7–36)NH2, GLP-1-(7–37), and GLP-1-(9–36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab. 2003;88:1772–1779.

  • Batterham, R. L., et al. Gut hormone PYY(3-36) physiologically inhibits food
  • intake. Nature. 418, 650-654 (2002).
  • Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev.2005;85(2):495–

522

  • Brockmeier U, Caspers M, Freudl R, Jockwer A, Noll T, et al. “Systematic screening
  • f all signal peptides from Bacillus subtilis: a powerful strategy in optimizing

heterologous protein secretion in Gram-positive bacteria” J Mol Biol . (2006) 362: 393–402

  • Korotkov, Konstantin V., Maria Sandkvist, and Wim G. J. Hol. “The Type II Secretion

System: Biogenesis, Molecular Architecture and Mechanism.”Nature reviews. Microbiology 10.5 (2012): 336–351. PMC. Web. 18 Sept. 2015.

  • Federle, Michael J., and Bonnie L. Bassler. “Interspecies Communication in

Bacteria.” Journal of Clinical Investigation112.9 (2003): 1291–1299. PMC. Web. 13 July 2015.

  • Weiss, L. E., Badalamenti, J. P., Weaver, L. J., Tascone, A. R., Weiss, P. S., Richard, T.
  • L. and Cirino, P. C. (2008), Engineering motility as a phenotypic response to LuxI/R-

dependent quorum sensing in Escherichia coli. Biotechnol. Bioeng., 100: 1251–1255.